Tello VS, De Matos Correia EVAO, Carpio VWC

Language: Spanish
References: 9
Page: 1-10
PDF size: 333.51 Kb.

ABSTRACT

Introduction: Acute leukemias of ambiguous lineage represent a heterogeneous group of leukemias without a clear differentiation of the cell lineage. They constitute about 2 to 5 % of all acute leukemias.
Objective: To describe a case of acute leukemia of mixed phenotype (LAFM) in a 4-year-old pediatric patient from Lambayeque, Peru.
Case presentation: A peripheral blood sample from a 4-year-old boy was evaluated, whose immunophenotype by flow cytometry showed a population, corresponding to 94 % of total cellularity, of myeloid lineages compatible with differentiation to neutrophil lineage and in less to monocytic/dendritic cell (CD123 high), with expression of myeloperoxidase (MPO) and CD33 high; CD13, CD64 and CD66c partial; and expression of B lymphoid lineage markers (CD19 and CD22 high). This phenotype requires ruling out the t (8; 21), and abnormalities of the MLL gene. Due to the aforementioned findings, the present leukemia was classified as acute leukemia of mixed phenotype, B/Myeloid.
Conclusions: It was concluded as an acute leukemia of mixed phenotype B/Myeloid, with the peculiar inclination of the myeloid lineage towards neutrophils and to a lesser extent towards monocytic/dendritic cell.

REFERENCES

1. Arber DA, Orazi A, Hasserjian R, Thiele J, Borowitz MJ, Le Beau MM, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016;127(20):2391-405 DOI: https://10.1182/blood-2016-03-643544

2. Marsán Suárez V, del Valle Pérez LO, Díaz Domínguez G, Macías Abraham C, Machín García S, Lam Díaz RM, et al. Correlación entre morfología y citometría de flujo en la Leucemia Linfoide Aguda Infantil. Rev Cubana Hematol Inmunol Hemoter [Internet]. 2016 Dic [acceso 20/01/2021];32(4):483-93. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-02892016000400007&lng=es.

3. Sukumaran R, Nair RA, Jacob PM, Anila KARN, Prem S, Binitha R, et al. Flow cytometric analysis of Mixed phenotype acute leukemia: Experience from a tertiary oncology center. Indian J Pathol Microbiol. 2015 Apr 1;58(2):181.

4. Charles NJ, Boyer DF. Mixed-Phenotype Acute Leukemia: Diagnostic Criteria and Pitfalls. Arch Pathol Lab Med. 2017;141(11):1462-8. DOI: https://10.5858/arpa.2017-0218-RA

5. Weinberg OK, Seetharam M, Ren L, Alizadeh A, Arber DA. Mixed phenotype acute leukemia: A study of 61 cases using World Health Organization and European Group for the Immunological Classification of Leukaemias criteria. Am J Clin Pathol. 2014 Dec;142(6):803-8.

6. Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016;127(20):2375-90. DOI: https://10.1182/blood-2016-01-643569

7. Lee HG, Baek HJ, Kim HS, Park SM, Hwang TJ, Kook H. Biphenotypic acute leukemia or acute leukemia of ambiguous lineage in childhood: clinical characteristics and outcome. Blood Res. 2019 Mar;54(1):63-73. DOI: https://10.5045/br.2019.54.1.63

8. Cortes CG. Leucemia aguda de fenotipo mixto. Estudio multicéntrico de supervivencia a largo plazo, factores pronósticos y resultados de tratamiento [Internet] [http://purl. org/dc/dcmitype /Text]. Universidad Miguel Hernández; 2017 [acceso 22/03/2021]. Disponible en: https://dialnet.unirioja.es/servlet/tesis?codigo=135021

9. MoyaS J, Pio DL. Parámetros bioquímicos enzimáticos (ALT, AST, ALP, ?-GT, LDH) en niños con leucemia linfoblástica aguda antes del tratamiento antineoplásico. Horiz. Med. [Internet]. 2015 Oct [acceso 20/02/2021];15(4):52-8. Disponible en: http://www.scielo.org.pe/scielo.php?script=sci_arttext&pid=S1727-558X2015000400008&lng=es.